SECOND LINE

Clinical trials for SECOND LINE explained in plain language.

Never miss a new study

Get alerted when new SECOND LINE trials appear

Sign up with your email to follow new studies for SECOND LINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New cocktail of cancer drugs shows promise for tough stomach tumors

Disease control Recruiting now

This study is for people with advanced stomach cancer that has spread and has already been treated once. It tests a combination of three drugs (ramucirumab, nal-IRI, and trifluridine/tipiracil) to see if they can shrink tumors and help people live longer. The goal is to control t…

Matched conditions: SECOND LINE

Phase: PHASE1, PHASE2 • Sponsor: National Health Research Institutes, Taiwan • Aim: Disease control

Last updated May 17, 2026 03:01 UTC

SECOND LINE

Get alerted when new SECOND LINE trials appear

New cocktail of cancer drugs shows promise for tough stomach tumors